BACKGROUND: The introduction of a pneumococcal conjugate vaccine has been associated with a shift in the serotypes responsible for bacteremic pneumococcal disease. We examined recent trends in serotypes responsible for disease and current risk factors among adults. METHODS: Data were obtained from 48 acute care hospitals in the 5-county region surrounding Philadelphia, Pennsylvania, from October 1, 2002, through September 30, 2008, on all hospitalized adult patients with community-acquired bacteremic pneumococcal disease. Isolates were serotyped and patient characteristics were compared with data from a household survey of the adult population in the region. RESULTS: During the study period, the annual rate of disease due to vaccine serotypes declined by 29% per year, but the rate of disease due to nonvaccine serotypes increased 13% per year, yielding an overall 7% increase in the annual rate of disease among adults. Advanced age was a risk factor for infection with nonvaccine serotypes compared with vaccine serotypes. Comparing all patients with the source population, African Americans were at increased risk of infection, and the presence of additional children in the home was associated with decreased risk of disease. Smoking, advanced age, and diabetes mellitus remained important risk factors in adults. CONCLUSIONS: New serotypes are replacing the serotypes covered in the conjugate vaccine. While some risk factors for pneumococcal disease remain unchanged, the observation that exposure to children in the home is associated with lower risk of disease suggests that the changing epidemiology of pneumococcal disease may be altering the dominant modes of transmission in the community.
BACKGROUND: The introduction of a pneumococcal conjugate vaccine has been associated with a shift in the serotypes responsible for bacteremic pneumococcal disease. We examined recent trends in serotypes responsible for disease and current risk factors among adults. METHODS: Data were obtained from 48 acute care hospitals in the 5-county region surrounding Philadelphia, Pennsylvania, from October 1, 2002, through September 30, 2008, on all hospitalized adult patients with community-acquired bacteremic pneumococcal disease. Isolates were serotyped and patient characteristics were compared with data from a household survey of the adult population in the region. RESULTS: During the study period, the annual rate of disease due to vaccine serotypes declined by 29% per year, but the rate of disease due to nonvaccine serotypes increased 13% per year, yielding an overall 7% increase in the annual rate of disease among adults. Advanced age was a risk factor for infection with nonvaccine serotypes compared with vaccine serotypes. Comparing all patients with the source population, African Americans were at increased risk of infection, and the presence of additional children in the home was associated with decreased risk of disease. Smoking, advanced age, and diabetes mellitus remained important risk factors in adults. CONCLUSIONS: New serotypes are replacing the serotypes covered in the conjugate vaccine. While some risk factors for pneumococcal disease remain unchanged, the observation that exposure to children in the home is associated with lower risk of disease suggests that the changing epidemiology of pneumococcal disease may be altering the dominant modes of transmission in the community.
Authors: K A Robinson; W Baughman; G Rothrock; N L Barrett; M Pass; C Lexau; B Damaske; K Stefonek; B Barnes; J Patterson; E R Zell; A Schuchat; C G Whitney Journal: JAMA Date: 2001-04-04 Impact factor: 56.272
Authors: J P Nuorti; J C Butler; M M Farley; L H Harrison; A McGeer; M S Kolczak; R F Breiman Journal: N Engl J Med Date: 2000-03-09 Impact factor: 91.245
Authors: Cynthia G Whitney; Monica M Farley; James Hadler; Lee H Harrison; Nancy M Bennett; Ruth Lynfield; Arthur Reingold; Paul R Cieslak; Tamara Pilishvili; Delois Jackson; Richard R Facklam; James H Jorgensen; Anne Schuchat Journal: N Engl J Med Date: 2003-05-01 Impact factor: 91.245
Authors: Brendan Flannery; Stephanie Schrag; Nancy M Bennett; Ruth Lynfield; Lee H Harrison; Arthur Reingold; Paul R Cieslak; James Hadler; Monica M Farley; Richard R Facklam; Elizabeth R Zell; Cynthia G Whitney Journal: JAMA Date: 2004-05-12 Impact factor: 56.272
Authors: William P Hausdorff; Greg Yothers; Ron Dagan; Terhi Kilpi; Stephen I Pelton; Robert Cohen; Michael R Jacobs; Sheldon L Kaplan; Corinne Levy; Eduardo L Lopez; Edward O Mason; Vassiliki Syriopoulou; Brian Wynne; John Bryant Journal: Pediatr Infect Dis J Date: 2002-11 Impact factor: 2.129
Authors: Eun Hwa Choi; So Hee Kim; Byung Wook Eun; Sun Jung Kim; Nam Hee Kim; Jina Lee; Hoan Jong Lee Journal: Emerg Infect Dis Date: 2008-02 Impact factor: 6.883
Authors: Richard G Wunderink; Wesley H Self; Evan J Anderson; Robert Balk; Sherene Fakhran; Daniel Mark Courtney; Chao Qi; Derek J Williams; Yuwei Zhu; Cynthia G Whitney; Matthew R Moore; Anna Bramley; Seema Jain; Kathryn M Edwards; Carlos G Grijalva Journal: Clin Infect Dis Date: 2018-05-02 Impact factor: 9.079
Authors: R Prymula; R Chlibek; I Ivaskeviciene; A Mangarov; Zs Mészner; P Perenovska; D Richter; N Salman; P Simurka; E Tamm; G Tešović; I Urbancikova; V Usonis Journal: Eur J Clin Microbiol Infect Dis Date: 2011-06-11 Impact factor: 3.267
Authors: K A Feemster; Y Li; A R Localio; J Shults; P Edelstein; E Lautenbach; T Smith; J P Metlay Journal: Epidemiol Infect Date: 2012-10-31 Impact factor: 2.451
Authors: S P Van Mens; A M M Van Deursen; S C A Meijvis; B J M Vlaminckx; E A M Sanders; H E De Melker; L M Schouls; A Van Der Ende; S C De Greeff; G T Rijkers Journal: Epidemiol Infect Date: 2013-11-11 Impact factor: 4.434